questionText: To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA, published on 2 April 2026, what measures are in place to monitor whether the accelerated access to new treatments is translating into measurable improvements in patient outcomes.
answerText: The Department will continue to work with the National Institute for Health and Care Excellence and NHS England to monitor and assess access to medicines in the United Kingdom and to monitor patient outcomes through the NHS Outcomes Framework Indicators.T...
heading: Medical Treatments: Standards